{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:04:09Z","timestamp":1784610249420,"version":"3.55.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>\n                    Bilateral macronodular adrenal disease (BMAD), also referred to as primary bilateral macronodular adrenal hyperplasia (PBMAH), represents a rare etiology of subclinical or overt Cushing\u2019s syndrome (CS), characterized by the presence of multiple large nodules in both adrenal glands. Although historically considered a sporadic condition, familial cases of BMAD have become increasingly recognized in recent years. As early surgical intervention is typically chosen for these familial cases, evidence on the long-term effectiveness of conservative medical therapy remains scarce. Here, we report a Japanese parent\u2013child pair with subclinical and overt CS with genetically confirmed BMAD in which both individuals harbored\n                    <jats:italic>ARMC5<\/jats:italic>\n                    mutations and exhibited aberrant hormone responses and were managed with long-term metyrapone monotherapy. In both cases, sustained biochemical control of adrenocortical hyperfunction was achieved in more than 5 years. One patient developed progressive hypokalemia, eventually leading to unilateral adrenalectomy. These findings suggest that metyrapone monotherapy serves as an effective noninvasive treatment strategy for select familial BMAD patients, although close monitoring is warranted for potential complications.\n                  <\/jats:p>","DOI":"10.3389\/fendo.2026.1852080","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:20:11Z","timestamp":1784607611000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: a family presenting with \u03b2-adrenergic\/vasopressin-responsive bilateral macronodular adrenal disease with an ARMC5 mutation treated with metyrapone monotherapy for more than 5 years"],"prefix":"10.3389","volume":"17","author":[{"given":"Masanori","family":"Arai","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City University","place":["Yokohama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City University","place":["Yokohama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City University","place":["Yokohama, Japan"]},{"name":"Laboratory of Diabetes and Metabolic Disorders, Institute for Molecular and Cellular Regulation (IMCR), Gunma University","place":["Maebashi, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Tajima","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City University","place":["Yokohama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Aomori","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Yokohama City University","place":["Yokohama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Tatenuma","sequence":"additional","affiliation":[{"name":"Department of Urology, Graduate School of Medicine, Yokohama City University","place":["Yokohama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawako","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University","place":["Chiba, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Yamanaka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yokohama City University Hospital","place":["Yokohama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yokohama City University Hospital","place":["Yokohama, Japan"]},{"name":"Department of Molecular Pathology, Yokohama City University Graduate School of Medicine","place":["Yokohama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Terauchi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City University","place":["Yokohama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shirakawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Graduate School of Medicine, Yokohama City University","place":["Yokohama, Japan"]},{"name":"Laboratory of Diabetes and Metabolic Disorders, Institute for Molecular and Cellular Regulation (IMCR), Gunma University","place":["Maebashi, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.11.5534","article-title":"Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome","volume":"86","author":"Bourdeau","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(24)00200-6","article-title":"Aberrant hormone receptors regulate a wide spectrum of endocrine tumors","volume":"12","author":"Lacroix","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1215245","article-title":"Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia","volume":"369","author":"Louiset","year":"2013","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4237","article-title":"ARMC5 mutations are a frequent cause of primary macronodular adrenal hyperplasia","volume":"99","author":"Alencar","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4204","article-title":"ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: Clinical and functional consequences","volume":"100","author":"Espiard","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1265","article-title":"ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia","volume":"99","author":"Gagliardi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1530\/eje-15-0642","article-title":"ARMC5 mutations in a large French-Canadian family with cortisol-secreting beta-adrenergic\/vasopressin responsive bilateral macronodular adrenal hyperplasia","volume":"174","author":"Bourdeau","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191602","article-title":"ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia","volume":"13","author":"Yu","year":"2018","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.ej17-0317","article-title":"Whole-genome sequencing revealed armadillo repeat containing 5 (ARMC5) mutation in a Chinese family with ACTH-independent macronodular adrenal hyperplasia","volume":"65","author":"Zhang","year":"2018","journal-title":"Endocrine J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(21)00236-9","article-title":"Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study","volume":"9","author":"Chasseloup","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2021.09.018","article-title":"KDM1A inactivation causes hereditary food-dependent Cushing syndrome","volume":"24","author":"Vaczlavik","year":"2022","journal-title":"Genet Medicine: Off J Am Coll Med Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome","volume":"369","author":"Assie","year":"2013","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304603","article-title":"Activating hotspot L205R mutation in PRKACA and adrenal Cushing\u2019s syndrome","volume":"344","author":"Cao","year":"2014","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1310359","article-title":"Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1210\/endrev\/bnac034","article-title":"Clinical, pathophysiologic, genetic, and therapeutic progress in primary bilateral macronodular adrenal hyperplasia","volume":"44","author":"Bertherat","year":"2023","journal-title":"Endocr Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.48.665","article-title":"Rational, effective metyrapone treatment of ACTH-independent bilateral macronodular adrenocortical hyperplasia (AIMAH)","volume":"48","author":"Omori","year":"2001","journal-title":"Endocrine J"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-011-9549-z","article-title":"Assessment of long-term efficacy and safety of metyrapone monotherapy in a patient with ACTH-independent macronodular adrenal hyperplasia","volume":"41","author":"Yoshida","year":"2012","journal-title":"Endocrine"},{"key":"B18","article-title":"Adrenal preclinical Cushing\u2019s syndrome","volume-title":"Annual Report of the Ministry of Health and Welfare \u201cDisorder of Adrenal Hormones\u201d Research Committee, Japan","author":"Nawata","year":"1996"},{"key":"B19","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2008.06.011","article-title":"Hyper-responsiveness of adrenal gland to vasopressin resulting in enhanced plasma cortisol in patients with adrenal nodule(s)","volume":"29","author":"Suzuki","year":"2008","journal-title":"Peptides"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.ej23-0593","article-title":"Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan","volume":"71","author":"Ogawa","year":"2024","journal-title":"Endocrine J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02638","article-title":"Mifepristone treatment in four cases of primary bilateral macronodular adrenal hyperplasia (BMAH)","volume":"104","author":"Cohan","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1530\/erc-20-0102","article-title":"Mass spectrometry-based steroid profiling in primary bilateral macronodular adrenocortical hyperplasia","volume":"27","author":"Hannah-Shmouni","year":"2020","journal-title":"Endocrine-Related Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaa162","article-title":"Volumetric modeling of adrenal gland size in primary bilateral macronodular adrenocortical hyperplasia","volume":"5","author":"Wurth","year":"2021","journal-title":"J Endocr Soc"},{"key":"B25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2265.2005.02412.x","article-title":"Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients","volume":"64","author":"Hoshiro","year":"2006","journal-title":"Clin Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/96.3.334","article-title":"Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia as a distinct subtype of Cushing's syndrome. Enzyme histochemical and ultrastructural study of four cases with a review of the literature","volume":"96","author":"Aiba","year":"1991","journal-title":"Am J Clin Pathol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.ijem_260_23","article-title":"Efficacy and\u00a0safety of osilodrostat in managing Cushing's syndrome: a systematic review and meta-analysis","volume":"28","author":"Nagendra","year":"2024","journal-title":"Indian J Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4280","article-title":"Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation","volume":"99","author":"Faucz","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac483","article-title":"ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia","volume":"50","author":"Lao","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1530\/eje-21-1032","article-title":"Identification of predictive criteria for pathogenic variants of primary bilateral macronodular adrenal hyperplasia (PBMAH) gene ARMC5 in 352 unselected patients","volume":"187","author":"Bouys","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac041","article-title":"An overview of the heterogeneous causes of Cushing syndrome resulting from primary macronodular adrenal hyperplasia (PMAH)","volume":"6","author":"Charchar","year":"2022","journal-title":"J Endocr Soc"},{"key":"B32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13023-025-03554-1","article-title":"The mutational landscape of ARMC5 in primary bilateral macronodular adrenal hyperplasia: an update","volume":"20","author":"Bouys","year":"2025","journal-title":"Orphanet J Rare Dis"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1852080\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:20:13Z","timestamp":1784607613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1852080\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":32,"alternative-id":["10.3389\/fendo.2026.1852080"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1852080","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"article-number":"1852080"}}